Thursday, January 21, 2010 11:57:46 PM
I know you don't do drug stocks, but keep HNAB on high alert tomorrow. Chart is crazy ready, and biomedical reports a short term target of .60 to .80 and much more with FDA approval.
article:http://biomedreports.com/articles/most-popular/25689-hana-biosciences-otchnab-set-for-a-comeback.html
Chart:
article:http://biomedreports.com/articles/most-popular/25689-hana-biosciences-otchnab-set-for-a-comeback.html
Chart:
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
